Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08AZK
|
||||
Former ID |
DNC005620
|
||||
Drug Name |
3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527456] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H12BrN
|
||||
Canonical SMILES |
C1CC(=CC2=CN=CC=C2)C3=C1C=C(C=C3)Br
|
||||
InChI |
1S/C15H12BrN/c16-14-5-6-15-12(3-4-13(15)9-14)8-11-2-1-7-17-10-11/h1-2,5-10H,3-4H2/b12-8+
|
||||
InChIKey |
QWAFSKBCSGIDRF-XYOKQWHBSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527456] | |
Cytochrome P450 19 | Target Info | Inhibitor | [527456] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Ovarian Infertility Genes | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.